Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PRECISION DIAGNOSTICS, LLC

NPI: 1063811941 · INDIANAPOLIS, IN 46240 · Clinical Medical Laboratory · NPI assigned 08/18/2014

$3K
Total Medicaid Paid
3,073
Total Claims
2,939
Beneficiaries
27
Codes Billed
2018-01
First Month
2018-04
Last Month

Provider Details

Authorized OfficialSCHAFFNER, NATHAN (VICE PRESIDENT OF SALES)
NPI Enumeration Date08/18/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 3,073 $3K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 795 723 $1K
80361 140 138 $114.66
83992 110 108 $90.78
80363 75 75 $76.44
80346 105 103 $66.93
80358 130 128 $63.66
80359 110 108 $63.66
80353 110 108 $63.66
80349 109 107 $63.66
80373 130 128 $63.66
80356 110 108 $63.66
80354 130 128 $63.66
80348 130 128 $63.66
80372 130 128 $63.66
80365 140 138 $63.66
80325 46 46 $42.44
80360 46 46 $42.44
80364 54 52 $38.22
80345 84 82 $31.83
80368 74 72 $21.22
80355 78 76 $21.22
80370 59 57 $21.22
80366 74 72 $21.22
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 53 38 $0.00
80357 13 13 $0.00
80369 12 12 $0.00
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 26 17 $0.00